Big Gain For HTG Molecular Diagnostics, Inc.
Tue, Dec 27, 2022 at 06:40 PM
HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ) rocketted at $4.31, representing a gain of 39%. The stock got featured on our News Catalysts scanner on Fri, Dec 23, 2022 at 04:17 PM in the 'PUBLIC OFFERING' category. From Tue, Dec 13, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed, Dec 21, 2022 at $13.8 with a volume of 8M+.
About HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ)
HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.
Top 10 Gainers:
- Elys Game Technology Corp. (ELYS:NASDAQ), 111.91%
- LightJump Acquisition Corporation (LJAQ:NASDAQ), 98.95%
- Quotient Limited (QTNT:NASDAQ), 94.74%
- Pingtan Marine Enterprise Ltd. (PME:NASDAQ), 59.46%
- Starry Group Holdings Inc. Class A (STRY:NYSE), 58.23%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 57.26%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 39.57%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 39.03%
- Lanvin Group Holdings Limited (LANV:NYSE), 38.58%
- Neptune Wellness Solutions Inc. (NEPT:NASDAQ), 35.85%